Global Antibody Drug Conjugates Market Size, Share, and COVID-19 Impact Analysis, By Application (Blood Cancer, Breast Cancer, Ovary Cancer, Lung Cancer, Skin Cancer, Brain Tumor, and Other Applications), By Technology (Cleavable and Non-Cleavable), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032

Industry: Healthcare
RELEASE DATE May 2023
REPORT ID SI1954
PAGES 212
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis by Application
      2. Market Attractiveness Analysis by Technology
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increased expenditure in research and development (R&D)
    3. Restraints
      1. Low penetration
    4. Opportunities
      1. Increase in product launches and approvals
    5. Challenges
      1. Manufacturing Capacity and Supply Chain
  6. Global Antibody Drug Conjugates Market Analysis and Projection, By Application
    1. Segment Overview
    2. Blood Cancer
    3. Breast Cancer
    4. Ovary Cancer
    5. Skin Cancer
    6. Brain Tumor
    7. Other Applications
  7. Global Antibody Drug Conjugates Market Analysis and Projection, By Technology
    1. Cleavable
    2. Non-Cleavable
  8. Global Antibody Drug Conjugates Market, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Antibody Drug Conjugates Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Global Antibody Drug Conjugates Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Seagen, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2. TAKEDA PHARMACEUTICAL COMPANY LIMITED
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  AstraZeneca
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4. F. Hoffmann-La Roche Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.  Pfizer, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6. Daiichi Sankyo Company Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7. GlaxoSmithKline plc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Astellas Pharma, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9. ADC Therapeutics SA
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  2. Global Blood Cancer, Antibody Drug Conjugates Market, By Region, 2022-2032(USD Billion)
  3. Global Breast Cancer, Antibody Drug Conjugates Market, By Region, 2022-2032(USD Billion)
  4. Global Ovary Cancer, Antibody Drug Conjugates Market, By Region, 2022-2032(USD Billion)
  5. Global Lung Cancer, Antibody Drug Conjugates Market, By Region, 2022-2032(USD Billion)
  6. Global Skin Cancer, Antibody Drug Conjugates Market, By Region, 2022-2032(USD Billion)
  7. Global Brain Tumor, Antibody Drug Conjugates Market, By Region, 2022-2032(USD Billion)
  8. Global Other Applications, Antibody Drug Conjugates Market, By Region, 2022-2032(USD Billion)
  9. Global Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  10. Global Cleavable, Antibody Drug Conjugates Market, By Region, 2022-2032(USD Billion)
  11. Global Non-Cleavable, Antibody Drug Conjugates Market, By Region, 2022-2032(USD Billion)
  12. Global Antibody Drug Conjugates Market, By Region, 2022-2032(USD Billion)
  13. North America Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  14. North America Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  15. U.S. Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  16. U.S. Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  17. Canada Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  18. Canada Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  19. Mexico Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  20. Mexico Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  21. Europe Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  22. Europe Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  23. Germany Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  24. Germany Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  25. France Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  26. France Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  27. U.K. Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  28. U.K. Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  29. Italy Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  30. Italy Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  31. Spain Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  32. Spain Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  33. Asia Pacific Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  34. Asia Pacific Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  35. Japan Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  36. Japan Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  37. China Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  38. China Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  39. India Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  40. India Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  41. South America Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  42. South America Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  43. Brazil Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  44. Brazil Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  45. The Middle East and Africa Antibody Drug Conjugates Market, By Application, 2022-2032(USD   Billion)
  46. The Middle East and Africa Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)
  47. UAE Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  48. UAE Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion) 
  49. South Africa Antibody Drug Conjugates Market, By Application, 2022-2032(USD Billion)
  50. South Africa Antibody Drug Conjugates Market, By Technology, 2022-2032(USD Billion)

List of Figures 

  1. Global Antibody Drug Conjugates Market Segmentation
  2. Antibody Drug Conjugates Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Antibody Drug Conjugates Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Antibody Drug Conjugates Market
  20. Antibody Drug Conjugates Market Segmentation, By Application
  21. Antibody Drug Conjugates Market, For Blood Cancer, By Region, 2022-2032 ($ Billion)
  22. Antibody Drug Conjugates Market, For Breast Cancer, By Region, 2022-2032 ($ Billion)
  23. Antibody Drug Conjugates Market, For Ovary Cancer, By Region, 2022-2032 ($ Billion)
  24. Antibody Drug Conjugates Market, For Lung Cancer, By Region, 2022-2032 ($ Billion)
  25. Antibody Drug Conjugates Market, For Skin Cancer, By Region, 2022-2032 ($ Billion)
  26. Antibody Drug Conjugates Market, For Brain Tumor, By Region, 2022-2032 ($ Billion)
  27. Antibody Drug Conjugates Market, For Other Applications, By Region, 2022-2032 ($ Billion)
  28. Antibody Drug Conjugates Market Segmentation, By Technology
  29. Antibody Drug Conjugates Market, For Cleavable, By Region, 2022-2032 ($ Billion)
  30. Antibody Drug Conjugates Market, For Non-Cleavable, By Region, 2022-2032 ($ Billion)
  31. Seagen, Inc.: Net Sales, 2022-2032 ($ Billion)
  32. Seagen, Inc.: Revenue Share, By Segment, 2022 (%)
  33. Seagen, Inc.: Revenue Share, By Region, 2022 (%)
  34. TAKEDA PHARMACEUTICAL COMPANY LIMITED: Net Sales, 2022-2032 ($ Billion)
  35. TAKEDA PHARMACEUTICAL COMPANY LIMITED: Revenue Share, By Segment, 2022 (%)
  36. TAKEDA PHARMACEUTICAL COMPANY LIMITED: Revenue Share, By Region, 2022 (%)
  37. AstraZeneca: Net Sales, 2022-2032 ($ Billion)
  38. AstraZeneca: Revenue Share, By Segment, 2022 (%)
  39. AstraZeneca: Revenue Share, By Region, 2022 (%)
  40. F. Hoffmann-La Roche Ltd.: Net Sales, 2022-2032 ($ Billion)
  41. F. Hoffmann-La Roche Ltd.: Revenue Share, By Segment, 2022 (%)
  42. F. Hoffmann-La Roche Ltd.: Revenue Share, By Region, 2022 (%)
  43. Pfizer, Inc.: Net Sales, 2022-2032 ($ Billion)
  44. Pfizer, Inc.: Revenue Share, By Segment, 2022 (%)
  45. Pfizer, Inc.: Revenue Share, By Region, 2022 (%)
  46. Gilead Sciences, Inc.: Net Sales, 2022-2032 ($ Billion)
  47. Gilead Sciences, Inc.: Revenue Share, By Segment, 2022 (%)
  48. Gilead Sciences, Inc.: Revenue Share, By Region, 2022 (%)
  49. Daiichi Sankyo Company Limited: Net Sales, 2022-2032 ($ Billion)
  50. Daiichi Sankyo Company Limited: Revenue Share, By Segment, 2022 (%)
  51. Daiichi Sankyo Company Limited: Revenue Share, By Region, 2022 (%)
  52. GlaxoSmithKline plc.: Net Sales, 2022-2032 ($ Billion)
  53. GlaxoSmithKline plc.: Revenue Share, By Segment, 2022 (%)
  54. GlaxoSmithKline plc.: Revenue Share, By Region, 2022 (%)
  55. Astellas Pharma, Inc.: Net Sales, 2022-2032 ($ Billion)
  56. Astellas Pharma, Inc.: Revenue Share, By Segment, 2022 (%)
  57. Astellas Pharma, Inc.: Revenue Share, By Region, 2022 (%)
  58. ADC Therapeutics SA: Net Sales, 2022-2032 ($ Billion)
  59. ADC Therapeutics SA: Revenue Share, By Segment, 2022 (%)
  60. ADC Therapeutics SA: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2022
Tables & Figures:110
Pages:212
Countries covered:15
Companies covered::10
Forecast CAGR:10.7%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies